feed,title,long_url,short_url
MedRxiv,Effectiveness of Subcutaneous Casirivimab and Imdevimab Relative to no COVID-19 Antibody Treatment Among Patients Diagnosed With COVID-19 in the Ambulatory Setting,https://medrxiv.org/cgi/content/short/2022.06.20.22276636v1?rss=1,https://bit.ly/3zTa3Q7
